Scientific research has been at the heart of every breakthrough we’ve made in the fight against HIV and in order to stop HIV we need convenient, safe, and effective prevention options. As we search for innovative solutions to guide HIV prevention, we continue to conduct clinical trials of promising strategies to understand their effectiveness and safety across different populations at risk for HIV infection.
Groundbreaking research—the kind we need for HIV—must include diverse participants from all parts of the community. Although many research projects lack critical community voices, HelpFightHIV.org and Bridge HIV are committed to inclusive research studies. We must be at the table to make sure we are served well! Our fight against HIV is focused on achieving health equity for all so our research must be too.
Our innovative research is focused on helping fight HIV through several strategies, so whether it’s an HIV vaccine, a new way to do HIV testing or a new pill to prevent HIV, the goal is the same.
But, we need your help. Check out our current studies below and volunteer today!
can we put this in the telescpoe?.
HPTN 083 – Injectable PrEP
MTN 036 is testing a vaginal ring containing 2 different doses of the anti-HIV medication dapivirine. Vaginal rings that slowly release HIV medication over weeks or months (like contraceptive rings) could be an effective alternative to oral PrEP or vaginal gels. The main purpose of this research study is to find out how two different dose combinations of the study drug are absorbed and processed by the body and to better understand the safety of the study drug. Information from the study will be used to help develop vaginal rings in the future, including combination rings that could be used to prevent both pregnancy and HIV.
HPTN 083 – Injectable PrEP
MTN 036 is testing a vaginal ring containing 2 different doses of the anti-HIV medication dapivirine. Vaginal rings that slowly release HIV medication over weeks or months (like contraceptive rings) could be an effective alternative to oral PrEP or vaginal gels. The main purpose of this research study is to find out how two different dose combinations of the study drug are absorbed and processed by the body and to better understand the safety of the study drug. Information from the study will be used to help develop vaginal rings in the future, including combination rings that could be used to prevent both pregnancy and HIV.
HPTN 083 – Injectable PrEP
MTN 036 is testing a vaginal ring containing 2 different doses of the anti-HIV medication dapivirine. Vaginal rings that slowly release HIV medication over weeks or months (like contraceptive rings) could be an effective alternative to oral PrEP or vaginal gels. The main purpose of this research study is to find out how two different dose combinations of the study drug are absorbed and processed by the body and to better understand the safety of the study drug. Information from the study will be used to help develop vaginal rings in the future, including combination rings that could be used to prevent both pregnancy and HIV.
This is a test to see if we can put a telescope into a telescope.
MTN 036 is testing a vaginal ring containing 2 different doses of the anti-HIV medication dapivirine. Vaginal rings that slowly release HIV medication over weeks or months (like contraceptive rings) could be an effective alternative to oral PrEP or vaginal gels. The main purpose of this research study is to find out how two different dose combinations of the study drug are absorbed and processed by the body and to better understand the safety of the study drug. Information from the study will be used to help develop vaginal rings in the future, including combination rings that could be used to prevent both pregnancy and HIV.
HVTN 119 evaluates the safety and immune responses of two different vaccines administered via electroporation injection to answer the question “Do different combinations of the vaccines affect how a person’s immune system responds to the vaccines?”
HVTN 120 evaluates the safety and immune responses of one vaccine followed by one of two different protein vaccines to answer the question “Do different combinations and doses of the vaccines affect how a person’s immune system responds to the vaccines?”
